Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
NOETIK is an AI-native biotech focused on discovering and developing precision cancer therapies. We combine self-supervised machine learning and multimodal data generated in-house to identify targets and advance drugs from discovery to clinical development.
Headquartered in South San Francisco, CA with a hybrid, remote-friendly culture, we value flexibility, collaboration across biology, AI, engineering, and therapeutics, and strong scientific judgment.
Drug discovery and development is a decision-making problem. We are generating more data and building better models, but real impact comes from knowing which questions matter and what evidence actually impacts a program’s trajectory. We need scientists who can pair model-driven outputs with sharp therapeutic judgment to figure out which therapies should exist, and for whom.
Ultimately the gig is translating those outputs into defensible portfolio calls. This means being deep in biology and therapeutic concepts, while also being genuinely engaged with frontier AI and how that is changing how we work. You will be the architect of new and better systems for discovering and developing drugs.
You’ll join a cross-functional therapeutics team responsible for surfacing promising therapeutic opportunities, pressure-testing their scientific and translational logic, and shaping how programs move through the pipeline. We’re intentionally building a different kind of therapeutics group to support this work, because turning human foundation models / insights into new therapeutic concepts and real patient impact requires a fundamentally different way of working.
As such, the people who will thrive here are also fundamentally different. They bring an AI-native perspective, incorporating agentic tools and machine intelligence alongside their own domain expertise to reason through problems. They’re platform-first, always asking what an AI-native platform can see that nobody else can, and what that’s worth for therapeutic decisions. They’re a drug hunter that knows the difference between an interesting hypothesis and a viable therapeutic concept that can become a real molecule that reaches real patients. And they’re portfolio-oriented, optimizing for the company’s best collective shots and making principled decisions about where the greatest therapeutic opportunity lies.
Key Responsibilities:
The strongest candidates embrace uncertainty and treat new technology as a candidate baseline for scientific reasoning the moment it emerges. Curiosity drives them across disciplines, where they direct intelligent systems to explore ideas, challenge assumptions, and surface hypotheses they wouldn’t have found alone. But just as importantly, they bring judgment back. Meaning they can separate plausible outputs from meaningful outputs, recognize weak or circular reasoning, and can combine machine intelligence with deep biological and therapeutic discernment to make better decisions. And finally, they are company and portfolio builders rather than single-project owners. They hold strong scientific opinions, adapt when the evidence changes, and optimize for the company’s best path forward for success.
We’re building a company around the belief that ambitious science is a team sport. We’re headquartered in South San Francisco, CA with a hybrid, remote‑friendly culture. We believe flexibility and autonomy matter, but so does spending intentional time together. Throughout the year we come together for Quarterly Co‑working Weeks, monthly All Hands, and an annual company offsite to align on strategy, strengthen relationships, and recharge as a team. Whether it’s a whiteboard session, catered lunch, or our standing Boba Thursday tradition, we make space for the conversations that often lead to the best ideas.
NOETIK is an AI-native biotech using self-supervised machine learning and multimodal data generated in-house to discover and develop precision cancer therapies. The founding team has a track record of building technology‑enabled platforms and advancing drugs from discovery to clinical development. In a short period of time, the team has built one of the most significant proprietary multimodal cancer datasets for machine learning and demonstrated target discovery using self supervised learning models. Come build the future with us. For more information, visit https://www.noetik.ai/.
We believe that the highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other. We are committed to an open, diverse and inclusive culture for all employees. NOETIK is proud to be an equal opportunity employer and does not discriminate on the basis of race, color, citizenship status, national origin, ancestry, sex, sexual orientation, age, religion, creed, physical or mental disability, medical condition, marital status, veteran status and any other characteristics protected under applicable federal, state and local laws.